申请人:DAIICHI PHARMACEUTICAL CO., LTD.
公开号:EP1731513A1
公开(公告)日:2006-12-13
Novel compounds having excellent PPAR α/γ agonist effects and having desirable properties for medicaments are provided.
Peroxisome proliferator-activated receptor α/γ agonists of the general formula (I):
(wherein Q is an optionally-substituted benzene or pyridine ring; R1 and R2 each are an optionally-substituted phenyl group or 5- or 6-membered aromatic heterocyclic group; X Y, and Z are independently C, O, S or N; R3 to R9 each are a hydrogen atom, a lower alkyl group, etc.; n is an integer of 0 to 3).
本研究提供了具有极佳 PPAR α/γ 激动剂效果和理想药用特性的新型化合物。
通式 (I) 的过氧化物酶体增殖激活受体 α/γ 激动剂:
(其中Q是任选取代的苯环或吡啶环;R1和R2各自是任选取代的苯基或5或6元芳香杂环基团;X Y和Z独立地是C、O、S或N;R3至R9各自是氢原子、低级烷基等;n是0至3的整数)。